Literature DB >> 20805020

Regulatory T cell defect in APECED patients is associated with loss of naive FOXP3(+) precursors and impaired activated population.

Sini M Laakso1, Tuisku-Tuulia Laurinolli, Laura H Rossi, Anni Lehtoviita, Heikki Sairanen, Jaakko Perheentupa, Eliisa Kekäläinen, T Petteri Arstila.   

Abstract

The pathogenetic mechanisms of organ-specific autoimmune diseases remain obscured by the complexity of the genetic and environmental factors participating in the breakdown of tolerance. A unique opportunity to study the pathogenesis of human autoimmunity is provided by autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED), a rare inherited autoimmune disease caused by mutations in Autoimmune Regulator (AIRE) gene. Loss of AIRE function disrupts the deletion of autoreactive T cells and impairs the suppressive function of regulatory T (Treg) cells. Here we show by multiparameter flow cytometry that in healthy controls the peripheral naive Treg cell subset forms a slowly dividing, persistent reservoir of recent thymic emigrants (RTEs). In APECED patients the RTE Treg cells show accelerated turnover and shift to the activated pool and the RTE reservoir is depleted. Moreover, the activated Treg cell population in the patients expresses significantly less Forkhead box protein P3 (FOXP3) than in the healthy controls, consistent with the impairment of peripheral activation. Our results indicate that in addition to their thymic effects, loss-of-function mutations in AIRE disrupt the peripheral homeostasis and activation of Treg cells. This may synergize with failed negative selection to cause APECED.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20805020     DOI: 10.1016/j.jaut.2010.07.008

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  24 in total

1.  Re-establishing immunological self-tolerance in autoimmune disease.

Authors:  Shimon Sakaguchi; Fiona Powrie; Richard M Ransohoff
Journal:  Nat Med       Date:  2012-01-06       Impact factor: 53.440

Review 2.  Lessons from primary immunodeficiencies: Autoimmune regulator and autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.

Authors:  Gregory M Constantine; Michail S Lionakis
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

Review 3.  Control of central and peripheral tolerance by Aire.

Authors:  Todd C Metzger; Mark S Anderson
Journal:  Immunol Rev       Date:  2011-05       Impact factor: 12.988

Review 4.  Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy.

Authors:  Kai Kisand; Pärt Peterson
Journal:  J Clin Immunol       Date:  2015-07-05       Impact factor: 8.317

Review 5.  Shaping the repertoire of tumor-infiltrating effector and regulatory T cells.

Authors:  Peter A Savage; Daniel S Leventhal; Sven Malchow
Journal:  Immunol Rev       Date:  2014-05       Impact factor: 12.988

Review 6.  Aire and T cell development.

Authors:  Mark S Anderson; Maureen A Su
Journal:  Curr Opin Immunol       Date:  2010-12-14       Impact factor: 7.486

Review 7.  Central tolerance to self revealed by the autoimmune regulator.

Authors:  Alice Y Chan; Mark S Anderson
Journal:  Ann N Y Acad Sci       Date:  2015-11       Impact factor: 5.691

8.  Aire Enforces Immune Tolerance by Directing Autoreactive T Cells into the Regulatory T Cell Lineage.

Authors:  Sven Malchow; Daniel S Leventhal; Victoria Lee; Saki Nishi; Nicholas D Socci; Peter A Savage
Journal:  Immunity       Date:  2016-04-26       Impact factor: 31.745

9.  Expanded CD4(+) Effector/Memory T Cell Subset in APECED Produces Predominantly Interferon Gamma.

Authors:  Nelli Heikkilä; Sini M Laakso; Helga Mannerström; Eliisa Kekäläinen; Päivi Saavalainen; Hanna Jarva; Tommi P Arstila
Journal:  J Clin Immunol       Date:  2016-06-04       Impact factor: 8.317

Review 10.  Liver immunology.

Authors:  Dimitrios P Bogdanos; Bin Gao; M Eric Gershwin
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.